One of the current challenges in the monitoring of drug nanocarriers lies in the difficulties in
discriminating the carrier-bound signals from the bulk signals of probes. Environment …

The idea of using extracellular vesicles (EVs) for targeted drug delivery was first introduced
in 2011 and has since then gained increasing attention as promising new candidates in the …

Extracellular vesicles (EVs) are membrane-enclosed particles, heterogeneous in size,
shape, contents, biogenesis and structure. They are released by eukaryotic and prokaryotic …

Extracellular vesicles (EVs) are evolutionary well-conserved nano-sized membranous
vesicles that are secreted by both prokaryotic and eukaryotic cells. Recently, they have …

Extracellular vesicles are promising delivery vesicles for therapeutic RNAs. Small interfering
RNA (siRNA) conjugation to cholesterol enables efficient and reproducible loading of …

Extracellular vesicles (EVs) are recognized as next generation diagnostic biomarkers due to
their disease‐specific biomolecular cargoes and importance in cell–cell communications. A …

Exosome-like vesicles (ELVs) are nanovectors released by cells that are endowed with a
variety of molecules, including proteins, nucleic acids, and chemicals that reflect the …

The gut-brain-microbiota axis (GBMAx) coordinates bidirectional communication between
the gut and brain, and is increasingly recognized as playing a central role in physiology and …

Obstructive sleep apnea (OSA) is a highly prevalent worldwide public health problem that is
characterized by repetitive upper airway collapse leading to intermittent hypoxia …

Extracellular vesicles (EVs) are a frontier class of circulating biomarkers for the diagnosis
and prognosis of different diseases. These lipid structures afford various biomarkers such as …